Literature DB >> 25404045

NK cells and their ability to modulate T cells during virus infections.

Kevin D Cook1, Stephen N Waggoner2, Jason K Whitmire3.   

Abstract

Natural killer (NK) cells are important in protection against virus infections, and many viruses have evolved mechanisms to thwart NK cell activity. NK cells respond to inflammatory signals at an early stage of virus infection, resulting in proliferation, cytokine production, and cytolytic activity that can reduce virus loads. Moreover, the rapid kinetics of the NK cell response enables NK cells to influence other populations of innate immune cells, affect the inflammatory milieu, and guide adaptive immune responses to infection. Early NK cell interactions with other leukocytes can have long-lasting effects on the number and quality of memory T cells, as well as impact the exhaustion of T cells during chronic infections. The ability of NK cells to modulate T cell responses can be mediated through direct T-NK interactions, cytokine production, or indirectly through dendritic cells and other cell types. Herein, we summarize our current understanding of how NK cells interact with T cells, dendritic cells, B cells, and other cell types involved in adaptive immune responses to virus infection. We outline several mechanisms by which NK cells enhance or suppress adaptive immune response and long-lived immunological memory.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25404045      PMCID: PMC4266186          DOI: 10.1615/critrevimmunol.2014010604

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  268 in total

Review 1.  Natural killer cells in viral hepatitis: facts and controversies.

Authors:  Mario U Mondelli; Stefania Varchetta; Barbara Oliviero
Journal:  Eur J Clin Invest       Date:  2010-06-29       Impact factor: 4.686

Review 2.  Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.

Authors:  Swapnil V Vaidya; Porunelloor A Mathew
Journal:  Immunol Lett       Date:  2006-03-15       Impact factor: 3.685

3.  B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.

Authors:  W J Storkus; J R Dawson
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

Review 4.  Targeting natural killer cells and natural killer T cells in cancer.

Authors:  Eric Vivier; Sophie Ugolini; Didier Blaise; Christian Chabannon; Laurent Brossay
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

5.  NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

Authors:  Claudia Semino; Giovanna Angelini; Alessandro Poggi; Anna Rubartelli
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

6.  Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.

Authors:  Cristina Cerboni; Alessandra Zingoni; Marco Cippitelli; Mario Piccoli; Luigi Frati; Angela Santoni
Journal:  Blood       Date:  2007-04-03       Impact factor: 22.113

7.  Mobilization of natural killer cells inhibits development of collagen-induced arthritis.

Authors:  Jianmei W Leavenworth; Xiaoyang Wang; Carola Schellack Wenander; Pieter Spee; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

8.  Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation.

Authors:  Molly P Keppel; Liping Yang; Megan A Cooper
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

9.  Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.

Authors:  Michelle N Kelly; Mingquan Zheng; Sanbao Ruan; Jay Kolls; Alain D'Souza; Judd E Shellito
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

10.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

View more
  44 in total

Review 1.  Harnessing adaptive natural killer cells in cancer immunotherapy.

Authors:  Lisa L Liu; Aline Pfefferle; Vincent Oei Yi Sheng; Andreas T Björklund; Vivien Béziat; Jodie P Goodridge; Karl-Johan Malmberg
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

Review 2.  Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function.

Authors:  Sophie M Poznanski; Nicole G Barra; Ali A Ashkar; Jonathan D Schertzer
Journal:  Inflamm Res       Date:  2018-07-31       Impact factor: 4.575

Review 3.  NK cells in host responses to viral infections.

Authors:  Viola C Lam; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2016-12-13       Impact factor: 7.486

4.  Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.

Authors:  Jeffrey J Teoh; Awndre E Gamache; Alyssa L Gillespie; Michael D Stadnisky; Hideo Yagita; Timothy N J Bullock; Michael G Brown
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

5.  Inclusion criteria: how NK cells gain access to T cells.

Authors:  Tonya J Webb
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

Review 6.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 7.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

Review 8.  Aging and Options to Halt Declining Immunity to Virus Infections.

Authors:  Miguel Ángel Palacios-Pedrero; Albert D M E Osterhaus; Tanja Becker; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

9.  SARS-CoV-2 associated with death in an infant with congenital chylothorax.

Authors:  Handan Bezirganoglu; Nilufer Okur
Journal:  J Paediatr Child Health       Date:  2021-05-18       Impact factor: 1.929

10.  Mucosal Vaccination Primes NK Cell-Dependent Development of CD8+ T Cells Against Pulmonary Brucella Infection.

Authors:  Ella Bhagyaraj; Hongbin Wang; Xinghong Yang; Carol Hoffman; Ali Akgul; Zakia I Goodwin; David W Pascual
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.